2021 APASL药物性肝损伤共识指南解读

2021-08-28 北京中医药大学第一临床医学院 中西医结合肝病杂志

该指南特别强调了由于抗结核药、传统草药和膳食补充剂的使用而引起的DILI,对亚太地区DILI的诊断与治疗提供了指导意见。临床实践中,应在指南指导下,针对患者的具体病情,制定最佳临床诊疗方案。 

中文标题:

2021 APASL药物性肝损伤共识指南解读

发布日期:

2021-08-28

简要介绍:

2021年2月27日,亚太肝病研究学会(APASL)在线发表了《药物性肝损伤:APASL共识指南》,对药物性肝损伤(DILI)的流行病学、诊断、治疗及预防做了简要说明,包括有关DILI的最新循证医学证据。基于亚太地区结核病的高发病率及草药和膳食补充剂的普遍使用,该指南特别强调了由于抗结核药、传统草药和膳食补充剂的使用而引起的DILI,对亚太地区DILI的诊断与治疗提供了指导意见。临床实践中,应在指南指导下,针对患者的具体病情,制定最佳临床诊疗方案。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021_APASL药物性肝损伤共识指南解读.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a4c951c00229520c, title=2021 APASL药物性肝损伤共识指南解读, enTitle=, guiderFrom=中西医结合肝病杂志 , authorId=0, author=, summary=该指南特别强调了由于抗结核药、传统草药和膳食补充剂的使用而引起的DILI,对亚太地区DILI的诊断与治疗提供了指导意见。临床实践中,应在指南指导下,针对患者的具体病情,制定最佳临床诊疗方案。 , cover=https://img.medsci.cn/20211218/1639838302489_5579292.png, journalId=0, articlesId=null, associationId=2236, associationName=北京中医药大学第一临床医学院, associationIntro=北京中医药大学第一临床医学院, copyright=0, guiderPublishedTime=Sat Aug 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">2021年2月27日,亚太肝病研究学会(APASL)在线发表了《药物性肝损伤:APASL共识指南》,对药物性肝损伤(DILI)的流行病学、诊断、治疗及预防做了简要说明,包括有关DILI的最新循证医学证据。基于亚太地区结核病的高发病率及草药和膳食补充剂的普遍使用,该指南特别强调了由于抗结核药、传统草药和膳食补充剂的使用而引起的DILI,对亚太地区DILI的诊断与治疗提供了指导意见。临床实践中,应在指南指导下,针对患者的具体病情,制定最佳临床诊疗方案。&nbsp;</span></p>, tagList=[TagDto(tagId=605, tagName=药物性肝损伤), TagDto(tagId=6634, tagName=肝脏疾病)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=605, guiderKeyword=药物性肝损伤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4158, appHits=267, showAppHits=0, pcHits=720, showPcHits=3890, likes=1, shares=31, comments=12, approvalStatus=1, publishedTime=Sat Dec 18 22:35:28 CST 2021, publishedTimeString=2021-08-28, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Dec 18 22:42:26 CST 2021, updatedBy=6415643, updatedName=凯晨, updatedTime=Sat Jan 06 22:30:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021_APASL药物性肝损伤共识指南解读.pdf)])
2021_APASL药物性肝损伤共识指南解读.pdf
下载请点击:
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2092697, encodeId=97f0209269ef0, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29cf4705638, createdName=ye.song, createdTime=Sun Oct 09 18:02:36 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209253, encodeId=ac9a12092531e, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bdd5596550, createdName=清漩, createdTime=Thu Apr 07 15:56:43 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204725, encodeId=bf981204e2568, content=分享给我师姐啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9AUwkzqhABDln6bABnW52sMcs8aPhQTiadEGygLABibaeBfbd437Votsxfd8GMdyAsYSpYczFHPLs3kwoibra0SQ/132, createdBy=b6fb2340836, createdName=ms6903418467290158, createdTime=Mon Mar 21 20:41:56 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185462, encodeId=2c04118546247, content=很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5df46454127, createdName=ms3000001873717261, createdTime=Tue Jan 18 06:47:07 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181422, encodeId=49ba1181422c0, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe15705834, createdName=ms4000001809038213, createdTime=Thu Jan 06 18:56:16 CST 2022, time=2022-01-06, status=1, ipAttribution=)]
    2022-10-09 ye.song

    学习了,谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2092697, encodeId=97f0209269ef0, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29cf4705638, createdName=ye.song, createdTime=Sun Oct 09 18:02:36 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209253, encodeId=ac9a12092531e, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bdd5596550, createdName=清漩, createdTime=Thu Apr 07 15:56:43 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204725, encodeId=bf981204e2568, content=分享给我师姐啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9AUwkzqhABDln6bABnW52sMcs8aPhQTiadEGygLABibaeBfbd437Votsxfd8GMdyAsYSpYczFHPLs3kwoibra0SQ/132, createdBy=b6fb2340836, createdName=ms6903418467290158, createdTime=Mon Mar 21 20:41:56 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185462, encodeId=2c04118546247, content=很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5df46454127, createdName=ms3000001873717261, createdTime=Tue Jan 18 06:47:07 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181422, encodeId=49ba1181422c0, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe15705834, createdName=ms4000001809038213, createdTime=Thu Jan 06 18:56:16 CST 2022, time=2022-01-06, status=1, ipAttribution=)]
    2022-04-07 清漩

    学习#学习#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2092697, encodeId=97f0209269ef0, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29cf4705638, createdName=ye.song, createdTime=Sun Oct 09 18:02:36 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209253, encodeId=ac9a12092531e, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bdd5596550, createdName=清漩, createdTime=Thu Apr 07 15:56:43 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204725, encodeId=bf981204e2568, content=分享给我师姐啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9AUwkzqhABDln6bABnW52sMcs8aPhQTiadEGygLABibaeBfbd437Votsxfd8GMdyAsYSpYczFHPLs3kwoibra0SQ/132, createdBy=b6fb2340836, createdName=ms6903418467290158, createdTime=Mon Mar 21 20:41:56 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185462, encodeId=2c04118546247, content=很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5df46454127, createdName=ms3000001873717261, createdTime=Tue Jan 18 06:47:07 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181422, encodeId=49ba1181422c0, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe15705834, createdName=ms4000001809038213, createdTime=Thu Jan 06 18:56:16 CST 2022, time=2022-01-06, status=1, ipAttribution=)]
    2022-03-21 ms6903418467290158

    分享给我师姐啦

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2092697, encodeId=97f0209269ef0, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29cf4705638, createdName=ye.song, createdTime=Sun Oct 09 18:02:36 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209253, encodeId=ac9a12092531e, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bdd5596550, createdName=清漩, createdTime=Thu Apr 07 15:56:43 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204725, encodeId=bf981204e2568, content=分享给我师姐啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9AUwkzqhABDln6bABnW52sMcs8aPhQTiadEGygLABibaeBfbd437Votsxfd8GMdyAsYSpYczFHPLs3kwoibra0SQ/132, createdBy=b6fb2340836, createdName=ms6903418467290158, createdTime=Mon Mar 21 20:41:56 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185462, encodeId=2c04118546247, content=很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5df46454127, createdName=ms3000001873717261, createdTime=Tue Jan 18 06:47:07 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181422, encodeId=49ba1181422c0, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe15705834, createdName=ms4000001809038213, createdTime=Thu Jan 06 18:56:16 CST 2022, time=2022-01-06, status=1, ipAttribution=)]
    2022-01-18 ms3000001873717261

    很有帮助

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2092697, encodeId=97f0209269ef0, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29cf4705638, createdName=ye.song, createdTime=Sun Oct 09 18:02:36 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209253, encodeId=ac9a12092531e, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bdd5596550, createdName=清漩, createdTime=Thu Apr 07 15:56:43 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204725, encodeId=bf981204e2568, content=分享给我师姐啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9AUwkzqhABDln6bABnW52sMcs8aPhQTiadEGygLABibaeBfbd437Votsxfd8GMdyAsYSpYczFHPLs3kwoibra0SQ/132, createdBy=b6fb2340836, createdName=ms6903418467290158, createdTime=Mon Mar 21 20:41:56 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185462, encodeId=2c04118546247, content=很有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5df46454127, createdName=ms3000001873717261, createdTime=Tue Jan 18 06:47:07 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181422, encodeId=49ba1181422c0, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe15705834, createdName=ms4000001809038213, createdTime=Thu Jan 06 18:56:16 CST 2022, time=2022-01-06, status=1, ipAttribution=)]
    2022-01-06 ms4000001809038213

    感谢分享

    0

拓展阅读

2014 ACG 药物性肝损伤诊断和管理临床指南

美国胃肠病学院(ACG,American College of Gastroenterology) · 2014-06-17

药物性肝损伤诊治指南2015版

中华医学会肝病学分会(Chinese Society of Hepatology, CMA) · 2016-06-02

2016 血液病患者药物性肝损伤的预防和规范化治疗专家共识(2016年版)

中国临床肿瘤学会(CSCO,Chinese Society of Clinical Oncology) · 2016-06-30

2019 EASL临床实践指南:药物性肝损伤

欧洲肝脏研究学会(EASL,European Association for the Study of the Liver) · 2019-03-26

药物性肝损伤基层诊疗指南(2019年)

中华医学会(CMA,Chinese Medical Association) · 2020-10-20